Skip to main content
OpenTrials

Clinical trial condition

Hematologic Diseases

Explore clinical trials studying Hematologic Diseases. Study availability and eligibility vary by location and protocol.

15,344 public trials 2,835 recruiting studies
Refine in advanced search Browse all conditions

Hematologic Diseases trial results

Active, Not Recruiting

A Study to Determine the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of AG-348 in Adult Participants With Non-transfusion-dependent Thalassemia

NCT03692052

Conditions
Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +6 more
Locations
  • UCSF Benioff Children's Hospital Oakland Oakland, California, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • University Health Network (Toronto General Hospital) Toronto, Ontario, Canada
  • Imperial College Healthcare NHS Trust (Hammersmith Hospital) London, United Kingdom
View Trial Details
Active, Not Recruiting

Dose Optimization and Expansion Study of DFV890 in Adult Patients With Myeloid Diseases

NCT05552469

Conditions
Bone Marrow Diseases, Chronic Disease, Disease Attributes, +12 more
Locations
  • Stanford Cancer Center Stanford, California, United States
  • H Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
  • Northwestern University Chicago, Illinois, United States
  • Sidney Kimmel CCC At JH Baltimore, Maryland, United States
View all 26 locations
View Trial Details
Active, Not Recruiting

Radiation- and Alkylator-free Bone Marrow Transplantation Regimen for Patients With Dyskeratosis Congenita

NCT01659606

Conditions
Anemia, Anemia, Aplastic, Aplastic Anemia, +18 more
Locations
  • University of Chicago Chicago, Illinois, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Boston Children's Hospital (pediatric patients) Boston, Massachusetts, United States
  • Dana-Farber Cancer Institute (adult patients) Boston, Massachusetts, United States
View all 13 locations
View Trial Details
Active, Not Recruiting

Ruxolitinib + Allogeneic Stem Cell Transplantation in AML

NCT03286530

Conditions
Acute Myeloid Leukemia, Acute Myeloid Leukemia in Remission, Allogeneic Stem Cell Transplantation, +7 more
Locations
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Washington University St Louis, Missouri, United States
  • The Ohio State University Columbus, Ohio, United States
View Trial Details
Active, Not Recruiting

A Study of CPI-613 for Patients With Relapsed or Refractory Burkitt Lymphoma/Leukemia or High-Grade B-Cell Lymphoma With High-Risk Translocations

NCT03793140

Conditions
Burkitt Lymphoma, DNA Virus Infections, Epstein-Barr Virus Infections, +16 more
Locations
  • City of Hope Duarte, California, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Memorial Sloan Kettering Basking Ridge Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth Middletown, New Jersey, United States
View Trial Details
Active, Not Recruiting

Study of ABBV-383 Assessing Adverse Events and Clinical Activity With Subcutaneous (SC) Injection in Adult Participants With Relapsed or Refractory Multiple Myeloma

NCT06223516

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Mayo Clinic Arizona /ID# 260799 Phoenix, Arizona, United States
  • Mayo Clinic Hospital Jacksonville /ID# 262808 Jacksonville, Florida, United States
  • Sylvester Comprehensive Cancer Center /ID# 260798 Miami, Florida, United States
  • University of Michigan Comprehensive Cancer Center Michigan Medicine /ID# 261050 Ann Arbor, Michigan, United States
View all 15 locations
View Trial Details

Related conditions